Nature medicine · 2021
Mitochondrial DNA variants modulate N-formylmethionine, proteostasis and risk of late-onset human diseases.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cai Na, Gomez-Duran Aurora, Yonova-Doing Ekaterina, Kundu Kousik, Burgess Annette I, Golder Zoe J, Calabrese Claudia, Bonder Marc J, Camacho Marta, Lawson Rachael A, Li Lixin, Williams-Gray Caroline H, ICICLE-PD Study Group, Di Angelantonio Emanuele, Roberts David J, Watkins Nick A, Ouwehand Willem H, Butterworth Adam S, Stewart Isobel D, Pietzner Maik, Wareham Nick J, Langenberg Claudia, Danesh John, Walter Klaudia, Rothwell Peter M, Howson Joanna M M, Stegle Oliver, Chinnery Patrick F, Soranzo Nicole
Аннотация
Mitochondrial DNA (mtDNA) variants influence the risk of late-onset human diseases, but the reasons for this are poorly understood. Undertaking a hypothesis-free analysis of 5,689 blood-derived biomarkers with mtDNA variants in 16,220 healthy donors, here we show that variants defining mtDNA haplogroups Uk and H4 modulate the level of circulating N-formylmethionine (fMet), which initiates mitochondrial protein translation. In human cytoplasmic hybrid (cybrid) lines, fMet modulated both mitochondrial and cytosolic proteins on multiple levels, through transcription, post-translational modification and proteolysis by an N-degron pathway, abolishing known differences between mtDNA haplogroups. In a further 11,966 individuals, fMet levels contributed to all-cause mortality and the disease risk of several common cardiovascular disorders. Together, these findings indicate that fMet plays a key role in common age-related disease through pleiotropic effects on cell proteostasis.